Vialwirebiotech, curated
November 21, 2026, 5:24 PM
July 10, 2026
- 12:04 PM · Pharmaceutical Executive12:04 PM<![CDATA[FDA Pauses Release of New CRL’s Following Citizen’s Petition ]]> — Pharmaceutical Executive
- 12:00 PM · BioWorld12:00 PMFormer Astrazeneca employee settles insider trading charges — BioWorld
- 11:42 AM · BioPharma Dive11:42 AMGSK, Hansoh ADC extends survival in lung cancer study — BioPharma Dive
- 10:08 AM · Pharmaceutical Executive10:08 AM<![CDATA[FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMFate Therapeutics’ FT-839 gains IND clearance — BioWorld
- 9:00 AM · BioWorld9:00 AMAtsena selects ATSN-401 clinical candidate for Stargardt disease — BioWorld
- 9:00 AM · BioWorld9:00 AMRani collaborates with Pegbio on oral drug delivery in obesity — BioWorld
- 9:00 AM · BioWorld9:00 AMApertura Gene Therapy enters CRADA for Niemann-Pick disease — BioWorld
- 6:46 AM · Pharmaceutical Technology6:46 AMChinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA — Pharmaceutical Technology
- 6:32 AM · Pharmaceutical Technology6:32 AMIpsen set to rival Botox after duo of Phase III migraine wins — Pharmaceutical Technology
- 6:00 AM · Pharmaceutical Executive6:00 AM<![CDATA[U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels]]> — Pharmaceutical Executive
- 5:31 AM · Pharmaceutical Technology5:31 AMTeva and Polpharma Biologics sign global deal for ocrelizumab biosimilar — Pharmaceutical Technology
- 4:59 AM · Drug Discovery World4:59 AMAlchemab receives £25 million from British Business Bank — Drug Discovery World
- 4:47 AM · FT — Pharmaceuticals4:47 AMBayer sells stake in contraceptives business to Apollo in €3bn financing deal — FT — Pharmaceuticals
July 9, 2026
- 4:53 PM · BioPharma Dive4:53 PMRoche scraps two Ionis-partnered Huntington’s drugs — BioPharma Dive
- 12:31 PM · FT — Pharmaceuticals12:31 PMAstraZeneca shares slide after heart treatment disappoints in trial — FT — Pharmaceuticals
- 12:11 PM · Pharmaceutical Technology12:11 PMModerna secures up to 24 million RSV vaccine dose contract with Europe — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMForte, First Tracks soar on CD122 success in vitiligo; celiac next — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMGSK ends brain drug alliance with Alector — BioPharma Dive
- 11:00 AM · STAT News11:00 AMSTAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs — STAT News
- 9:47 AM · Pharmaceutical Executive9:47 AM<![CDATA[FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMU&S Bio identifies new H+/K+-ATPase inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMNuvalent discloses new AKT1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMGrant supports Rybodyn’s antibody therapies for lung cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMApolin Bio and Viva Biotech present new ApoA/APOB interaction inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMPromomed Rus discovers new JAK inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMUrogen’s UGN-501 gains IND clearance for bladder cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMPrelude Therapeutics patents new KAT6A-targeting PROTACs — BioWorld
- 7:48 AM · FT — Pharmaceuticals7:48 AMLeading UK research facility Diamond Light Source faces cost cuts — FT — Pharmaceuticals
- 6:30 AM · STAT News6:30 AMSTAT+: 931 days. The drug approval scandal hiding in plain sight — STAT News
- 5:13 AM · STAT News5:13 AMSTAT+: AstraZeneca, Ionis report major trial failure with heart disease drug — STAT News
- 5:07 AM · Pharmaceutical Technology5:07 AMEvogene and Tel Aviv University launch drug discovery initiative — Pharmaceutical Technology